Screener
Cogent Biosciences, Inc. COGT Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Cogent Biosciences, Inc.’s reported figures.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed August 10, 2026. Open the filing →
- Filed
- Aug 10, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-342393
FAQ
- What is Cogent Biosciences, Inc.'s free cash flow?
- Cogent Biosciences, Inc. (COGT) reported free cash flow of -$77.64M in Q2 2026.
- How has Cogent Biosciences, Inc.'s free cash flow changed year-over-year?
- Cogent Biosciences, Inc.'s free cash flow decreased by 42.0% year-over-year, from -$54.67M to -$77.64M.
- What is the long-term trend for Cogent Biosciences, Inc.'s free cash flow?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s free cash flow has grown at a 28.5% compound annual growth rate (CAGR), from -$125.5M to -$266M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Cogent Biosciences, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude